Health

Oral Breast Cancer Drug Wins Broader FDA Nod for ESR1-Mutated Disease

TribeNews
By TribeNews Add a Comment
0 Min Read
Oral Breast Cancer Drug Wins Broader FDA Nod for ESR1-Mutated Disease

MedPage Today) — The FDA approved the oral estrogen receptor antagonist imlunestrant (Inluriyo) for previously treated ESR1-mutated advanced/metastatic breast cancer, the agency announced Thursday.
The approval stipulates use in adults with…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app